Beranda › Penyakit Alzheimer › New York
Uji klinis Penyakit Alzheimer di New York
37 studi untuk Penyakit Alzheimer mencari peserta di lokasi di New York.
Kota di New York
- New York City21 studi
- Queens8 studi
- Newburgh5 studi
- Albany4 studi
- Staten Island4 studi
- Syracuse4 studi
- Rochester3 studi
- Buffalo3 studi
Teks studi resmi (Bahasa Inggris)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1656, New Windsor
- Local Institution - 2619, Staten Island
- Local Institution - 1658, Woodmere
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Alzheimer's Disease Research Center, Albany
Menerima pesertaFase 4
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07633470A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Mid Hudson Medical Research PLLC, New Windsor
- SUNY Upstate Medical University, Syracuse
- Five Towns Neurology, PC, Woodmere
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Alzheimer's Disease Research Center, Albany
- Adams Clinic Harlem, New York
Menerima pesertaFase 2
Usia 55 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Basil Clinical, Laurelton
- Weill Cornell Medical College, New York
- Adams Clinical Harlem, New York
- dan 2 lainnya
Menerima pesertaFase 3
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Neurological Associates Albany, Albany
- Dent Neurosciences Research Center, Inc, Amherst
- University at Buffalo - UBMD Neurology, Buffalo
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2647, Brooklyn
- Richmond Behavioral Associates, Staten Island
- Walnut Clinical Research, Valley Stream
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1610, Inwood
- Mid Hudson Medical Research, New Windsor
- Five Towns Neurology PC -Woodmere - 923 Broadway, Woodmere
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011732A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Basil Clinical, Laurelton
Menerima pesertaFase 3
Usia 55 hingga 80 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07717411Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University at Buffalo - UBMD Neurology, Buffalo
- The Feinstein Institute for Medical Research, Manhasset
- Mid Hudson Medical Research, New Windsor
- dan 1 lainnya
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alzheimer Disease Research Center (ADRC) ( Site 1000), Albany
- Mid Hudson Medical Research ( Site 1050), New Windsor
- Basil Clinical ( Site 1065), Queens
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- The Research Foundation for State University of New York, Buffalo
Menerima peserta
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07178210A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- NYU Langone Health, New York
- SUNY Upstate Medical University, Syracuse
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06976216Early Age-Related Hearing Loss Investigation (EARHLI)
- Columbia University Medical Center, New York
Menerima peserta
Usia 55 hingga 75 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06174038The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- New York University, New York
- Mount Sinai, New York
Menerima peserta
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05988385Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT04239079Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05552157Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
- NYU Rory Meyers College of Nursing and VNS Health, New York
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT07182357Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- Columbia University Irving Medical Center, New York
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04576793Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
- Weill Cornell Medicine Brain Health Imaging Institute, New York
Menerima pesertaFase 2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT07553338[18F]PI-2620 Phase 3 Histopathological Study
- Velocity Clinical Research, East Syracuse
- Ichor Research, Syracuse
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only, Staten Island
Menerima pesertaStudi observasional
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109Late Onset Alzheimer's Disease
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT05010603Tele-Savvy for Latino Caregivers
- University of Rochester School of Nursing, Rochester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07290387Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
Menerima pesertaFase 4
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT05004987Genetic Studies of Early-onset Dementia
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 35 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT04906863Tau Networks in Psychotic Alzheimer's Disease
- The Feinstein Institutes for Medical Research, Manhasset
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 65 hingga 85 · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT05847192Dementia Caregivers' Link to Assistance and Resources
- VNS Health Home Care, New York
Menerima pesertaSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06860035Evaluating the Efficacy of the Pain Identification and Communication Toolkit
- Weill Cornell Medicine, New York
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT06168604Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Staten Island
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT07105709Daridorexant to Prevent Post-cardiotomy Delirium
- University of Rochester Medical Center, Rochester
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT07217912Innate Immunity Stimulation Via TLR9 in Early AD
- NYU Langone Health, New York
Menerima pesertaFase 1
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT05606341NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Menerima pesertaStudi observasional
30 Days · Semua jenis kelamin · Diperbarui 3 Mar 2025 · NCT06203106Triage Survey for Neurology Research Eligibility
- Berman Clinical, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Okt 2023 · NCT06104852Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.